Clinician attitudes about commercial support of continuing medical education: Results of a detailed survey

Archives of Internal Medicine

Volumn 171, Issue 9, 2011, Pages 840-846

  Tabas, Jeffrey A ^a   Boscardin, Christy ^a   Jacobsen, Donna M ^a   Steinman, Michael A ^a   Volberding, Paul A ^a   Baron, Robert B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIAS; COST; DRUG INDUSTRY; ECONOMIC ASPECT; FEE; FUNDING; HUMAN; KNOWLEDGE; MEDICAL EDUCATION; PHYSICIAN ATTITUDE; PRIORITY JOURNAL; REGISTRATION FEE; STRUCTURED QUESTIONNAIRE; SYSTEMATIC ERROR; UNITED STATES; WILLINGNESS TO PAY;

ATTITUDE OF HEALTH PERSONNEL; BIAS (EPIDEMIOLOGY); COMMERCE; DRUG INDUSTRY; EDUCATION, MEDICAL, CONTINUING; FEMALE; FINANCIAL SUPPORT; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; QUESTIONNAIRES;

EID: 79955786241     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinternmed.2011.179     Document Type: Article

References (25)

1. Accreditation Council for Continuing Medical Education annual report data, 2006. http://www.accme.org/dir_docs/doc_upload/f51ed7d8-e3b4-479a-a9d8-57b6efedc27a_uploaddocument.pdf. Accessed July 1, 2009.
2. Institute of Medicine. Redesigning Continuing Education in the Health Professions. Washington, DC: National Academies Press; 2010.
3. Fletcher SW. Chairman's summary of the conference: continuing education in the health professions: improving healthcare through lifelong learning. J Contin Educ Nurs. 2008;39(3):112-118.
4. Lo B, Field MJ, eds. Institute of Medicine: Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009.
5. Steinbrook R. Financial support of continuing medical education. JAMA. 2008;299 (9):1060-1062.
6. American Medical Association. Physician Characteristics and Distribution in the U.S. Chicago, IL: Survey & Data Resources, American Medical Association; 2008.
7. ACCME Standards for Commercial Support: standards to ensure the independence of CME activities. 2007; http://www.accme.org/dir_docs/doc_upload /68b2902a-fb73-44d1-8725-80a1504e520c_uploaddocument.pdf. Accessed July 3, 2009.
8. Barnes BE, Cole JG, King CT, et al. A risk stratification tool to assess commercial influences on continuing medical education. J Contin Educ Health Prof. 2007; 27(4):234-240.
9. Takhar J, Dixon D, Donahue J, et al. Developing an instrument to measure bias in CME. J Contin Educ Health Prof. 2007;27(2):118-123.
10. Steinman MA, Baron RB. Is continuing medical education a drug-promotion tool? YES. Can Fam Physician. 2007;53(10):1650-1657.
11. Association of American Medical Colleges. Industry funding of medical education: report of an AAMC task force, 2008. https://services.aamc.org/publications /index.cfm?fuseaction=Product.displayForm&prd_id=232&prv_id=281. Accessed December 18,2009.
12. American Medical Association Council on Ethical and Judicial Affairs. Financial relationships with industry in continuing medical education, 2009. http://www.ama-assn.org/ama1/pub/upload/mm/475/ceja0109.pdf. Accessed December 20, 2009.
13. Report of the Council on Ethical and Judicial Affairs. Financial relationships with industry in continuing medical education, 2010. http://policymed.typepad.com /files/ama-hod---ceja-i---v.4.0-5-18-10.pdf. Accessed August 7, 2010.
14. Carney SL, Nair KR, Sales MA, Walsh J. Pharmaceutical industry-sponsored meetings: good value or just a free meal? Intern Med J. 2001;31(8):488-491.
15. Kawczak S, Carey W, Lopez R, Jackman D. The effect of industry support on participants' perceptions of bias in continuing medical education. Acad Med. 2010; 85(1):80-84.
16. Steinman MA, Boscardin CK, Aguayo L, Baron RB. Commercial influence and learner-perceived bias in continuing medical education. Acad Med. 2010;85 (1):74-79.
17. Rutledge P, Crookes D, McKinstry B, Maxwell SR. Do doctors rely on pharmaceutical industry funding to attend conferences and do they perceive that this creates a bias in their drug selection? results from a questionnaire survey. Pharmacoepidemiol Drug Saf. 2003;12(8):663-667.
18. Steinman MA, Shlipak MG, McPhee SJ. Of principles and pens: attitudes and practices of medicine housestaff toward pharmaceutical industry promotions. Am J Med. 2001;110(7):551-557.
19. Mueller PS, Hook CC, Litin SC. Physician preferences and attitudes regarding industry support of CME programs. Am J Med. 2007;120(3):281-285.
20. Steinbrook R. Controlling conflict of interest: proposals from the Institute of Medicine. N Engl J Med. 2009;360(21):2160-2163.
21. Relman AS. Industry support of medical education. JAMA. 2008;300(9):1071-1073.
22. Krupa C. Michigan med school drops commercial support for CME. 2010; http: //www.ama-assn.org/amednews/2010/07/26/prsa0726.htm. Accessed August 7, 2010.
23. Gritz ER, Sarna L, Dresler C, Healton CG. Building a united front: aligning the agendas for tobacco control, lung cancer research, and policy. Cancer Epidemiol Biomarkers Prev. 2007;16(5):859-863.
24. Steelfisher GK, Blendon RJ, Sussman T, Connolly JM, Benson JM, Herrmann MJ. Physicians' views of the Massachusetts Health Care Reform Law: a poll. N Engl J Med. 2009;361(19):e39.
25. Morton ME, Wiedenbeck S. A framework for predicting EHR adoption attitudes: a physician survey. Perspect Health Inf Manag. 2009;6:1a.